Skip to main content
Equibles

Igor Bluvstein

CFO

Revium Rx. (RVRC)

Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.

About Igor Bluvstein

Igor Bluvstein is recorded as CFO at Revium Rx. (RVRC). Revium Rx. reported in an 8-K filed June 1, 2026 that Igor Bluvstein was appointed Chief Financial Officer, effective May 27, 2026.

“On May 27, 2026, our Board of Directors appointed Mr. Igor Bluvstein to serve as the Chief Financial Officer of the Company and of its subsidiaries, effective immediately.”
Revium Rx. Form 8-K, filed June 1, 2026 · Read the filing

Summary generated from SEC filings and earnings-call records held by Equibles.

Affiliation history

Recorded current and former roles; source labels appear when available.

Company network

Recorded roles and call appearances connecting this person to public companies.

Leadership on record at Revium Rx.

Other people whose current roles at this company are on record from its filings.

Recent activity

Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.